These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30850835)

  • 1. The Power of Resolution: Contextualized Understanding of Biological Responses to Liver Injury Chemicals Using High-throughput Transcriptomics and Benchmark Concentration Modeling.
    Ramaiahgari SC; Auerbach SS; Saddler TO; Rice JR; Dunlap PE; Sipes NS; DeVito MJ; Shah RR; Bushel PR; Merrick BA; Paules RS; Ferguson SS
    Toxicol Sci; 2019 Jun; 169(2):553-566. PubMed ID: 30850835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benchmark Concentrations for Untargeted Metabolomics Versus Transcriptomics for Liver Injury Compounds in In Vitro Liver Models.
    Crizer DM; Ramaiahgari SC; Ferguson SS; Rice JR; Dunlap PE; Sipes NS; Auerbach SS; Merrick BA; DeVito MJ
    Toxicol Sci; 2021 May; 181(2):175-186. PubMed ID: 33749773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative and quantitative concentration-response modelling of gene co-expression networks to unlock hepatotoxic mechanisms for next generation chemical safety assessment.
    Kunnen SJ; Arnesdotter E; Willenbockel CT; Vinken M; van de Water B
    ALTEX; 2024; 41(2):213-232. PubMed ID: 38376873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of base-line and chemical-induced transcriptomic responses in HepaRG and RPTEC/TERT1 cells using TempO-Seq.
    Limonciel A; Ates G; Carta G; Wilmes A; Watzele M; Shepard PJ; VanSteenhouse HC; Seligmann B; Yeakley JM; van de Water B; Vinken M; Jennings P
    Arch Toxicol; 2018 Aug; 92(8):2517-2531. PubMed ID: 30008028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatotoxicity of silver nanoparticles: Benchmark concentration modeling of an in vitro transcriptomics study in human iPSC-derived hepatocytes.
    Gao X; Johnson WE; Yourick MR; Campasino K; Sprando RL; Yourick JJ
    Regul Toxicol Pharmacol; 2024 Aug; 151():105653. PubMed ID: 38825064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping Interindividual Variability of Toxicodynamics Using High-Throughput Transcriptomics and Primary Human Hepatocytes from Fifty Donors.
    Niemeijer M; Więcek W; Fu S; Huppelschoten S; Bouwman P; Baze A; Parmentier C; Richert L; Paules RS; Bois FY; van de Water B
    Environ Health Perspect; 2024 Mar; 132(3):37005. PubMed ID: 38498338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the dependency of in vitro benchmark concentrations on exposure time in transcriptomics experiments.
    Carpi D; Liska R; Malinowska JM; Palosaari T; Bouhifd M; Whelan M
    Toxicol In Vitro; 2024 Mar; 95():105761. PubMed ID: 38081393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Throughput Transcriptomics Differentiates Toxic versus Non-Toxic Chemical Exposures Using a Rat Liver Model.
    Pannala VR; Wallqvist A
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Transcriptomics of Nontumorigenic Breast Cells Exposed to Environmentally Relevant Chemicals.
    Sala-Hamrick KE; Tapaswi A; Polemi KM; Nguyen VK; Colacino JA
    Environ Health Perspect; 2024 Apr; 132(4):47002. PubMed ID: 38568856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empirical Characterization of False Discovery Rates of Differentially Expressed Genes and Transcriptomic Benchmark Concentrations in Zebrafish Embryos.
    Lee H; Stead JDH; Williams A; Cortés Ramírez SA; Atlas E; Mennigen JA; O'Brien JM; Yauk C
    Environ Sci Technol; 2024 Apr; 58(14):6128-6137. PubMed ID: 38530926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unlocking the Power of Transcriptomic Biomarkers in Qualitative and Quantitative Genotoxicity Assessment of Chemicals.
    Thienpont A; Cho E; Williams A; Meier MJ; Yauk CL; Rogiers V; Vanhaecke T; Mertens B
    Chem Res Toxicol; 2024 Mar; 37(3):465-475. PubMed ID: 38408751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Sequencing Depth and Library Preparation on Toxicological Interpretation of RNA-Seq Data in a "Three-Sample" Scenario.
    Li D; Gong B; Xu J; Ning B; Tong W
    Chem Res Toxicol; 2021 Feb; 34(2):529-540. PubMed ID: 33354967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A network-based transcriptomic landscape of HepG2 cells uncovering causal gene-cytotoxicity interactions underlying drug-induced liver injury.
    Wijaya LS; Gabor A; Pot IE; van de Have L; Saez-Rodriguez J; Stevens JL; Le Dévédec SE; Callegaro G; van de Water B
    Toxicol Sci; 2024 Feb; 198(1):14-30. PubMed ID: 38015832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screening and classification of chemicals and their effects on neuronal gene expression using RASL-seq.
    Simon JM; Paranjape SR; Wolter JM; Salazar G; Zylka MJ
    Sci Rep; 2019 Mar; 9(1):4529. PubMed ID: 30872602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating gene expression and splicing dynamics across dose-response oxidative modulators.
    Barutcu AR; Black MB; Samuel R; Slattery S; McMullen PD; Nong A
    Front Genet; 2024; 15():1389095. PubMed ID: 38846964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mining toxicogenomic data for dose-responsive pathways: implications in advancing next-generation risk assessment.
    Barutcu AR; Black MB; Nong A
    Front Toxicol; 2023; 5():1272364. PubMed ID: 38046401
    [No Abstract]   [Full Text] [Related]  

  • 17. Dataset on transcriptomic profiling of parenteral nutrition-induced hepatotoxicity in a human liver
    Mihajlovic M; Vinken M
    Data Brief; 2024 Aug; 55():110653. PubMed ID: 39040552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique challenges and best practices for single cell transcriptomic analysis in toxicology.
    Filipovic D; Kana O; Marri D; Bhattacharya S
    Curr Opin Toxicol; 2024 Jun; 38():. PubMed ID: 38645720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 5-day In Vivo Rat Liver and Kidney With High-throughput Transcriptomics for Estimating Benchmark Doses of Apical Outcomes.
    Gwinn WM; Auerbach SS; Parham F; Stout MD; Waidyanatha S; Mutlu E; Collins B; Paules RS; Merrick BA; Ferguson S; Ramaiahgari S; Bucher JR; Sparrow B; Toy H; Gorospe J; Machesky N; Shah RR; Balik-Meisner MR; Mav D; Phadke DP; Roberts G; DeVito MJ
    Toxicol Sci; 2020 Aug; 176(2):343-354. PubMed ID: 32492150
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.